Big things are happening in Texas in the field of nanomedicine. Backed by a four-year $2.1 million grant from the National Institutes of Health (NIH), the Bioengineering Department at the University of Texas at Arlington (UTA) is out to improve treatment for peripheral arterial disease (PAD).
Led by renowned UTA bioengineering professor Kytai Nguyen, the project aims to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat PAD.
“This cutting-edge technology has a chance to change our protocols on how to deal with atherosclerosis,” explained Michael Cho, chair of the UTA Bioengineering Department. He continued, “When you are able to target localized lesions for treatment, that is so much better for the patients and much less invasive than current treatment.”
Nanomedicine is making a big impact.
As the principal investigator on the project, Nguyen hopes to improve the treatment of PAD for patients and physicians alike. “What’s important in this project is that the technology carries fluorescent and ultrasound imaging capabilities, which will provide patients and doctors with more detailed information,” Nguyen said. “It also gives patients more targeted medicine, making it more efficient.”
REALITYRx can make an impact for you.
New medical advances are happening every day. As your marketing partner, we know how to make an impact when communicating your products, services, and the advances you have on the horizon.
Check out our latest thinking at realityrx.com/news.
